Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Mar 21 04:00PM ET
69.39
Dollar change
-1.06
Percentage change
-1.50
%
IndexS&P 500 P/E22.73 EPS (ttm)3.05 Insider Own1.60% Shs Outstand124.16M Perf Week-1.69%
Market Cap8.62B Forward P/E13.07 EPS next Y5.31 Insider Trans-1.08% Shs Float122.19M Perf Month-11.10%
Income390.00M PEG2.93 EPS next Q1.13 Inst Own105.07% Short Float4.75% Perf Quarter-5.18%
Sales12.67B P/S0.68 EPS this Y2.93% Inst Trans-1.43% Short Ratio3.13 Perf Half Y-4.24%
Book/sh27.33 P/B2.54 EPS next Y8.82% ROA3.75% Short Interest5.80M Perf Year-6.71%
Cash/sh0.98 P/C70.63 EPS next 5Y7.75% ROE11.07% 52W Range63.67 - 82.49 Perf YTD0.27%
Dividend Est.- P/FCF12.31 EPS past 5Y-2.15% ROI7.11% 52W High-15.88% Beta0.84
Dividend TTM- Quick Ratio0.78 Sales past 5Y5.23% Gross Margin29.71% 52W Low8.98% ATR (14)2.10
Dividend Ex-Date- Current Ratio1.42 EPS Y/Y TTM-3.26% Oper. Margin5.77% RSI (14)37.39 Volatility1.97% 3.35%
Employees25000 Debt/Eq0.85 Sales Y/Y TTM2.71% Profit Margin3.08% Recom2.44 Target Price80.23
Option/ShortYes / Yes LT Debt/Eq0.62 EPS Q/Q443.36% Payout0.00% Rel Volume0.79 Prev Close70.45
Sales Surprise-2.85% EPS Surprise-1.18% Sales Q/Q5.77% EarningsFeb 25 BMO Avg Volume1.86M Price69.39
SMA20-3.87% SMA50-7.05% SMA200-2.61% Trades Volume1,473,143 Change-1.50%
Date Action Analyst Rating Change Price Target Change
Feb-14-25Initiated Wells Fargo Equal Weight $80
Jan-06-25Upgrade BofA Securities Underperform → Buy $69 → $84
Dec-04-24Initiated Mizuho Neutral $75
Jul-22-24Upgrade Robert W. Baird Neutral → Outperform $81 → $92
Feb-26-24Initiated Leerink Partners Market Perform $78
Dec-12-23Upgrade JP Morgan Neutral → Overweight $71 → $82
Nov-10-23Upgrade Stifel Hold → Buy $70
Aug-08-22Upgrade UBS Sell → Neutral $80
Jul-21-22Downgrade Goldman Buy → Neutral $93 → $85
Jun-14-22Downgrade Robert W. Baird Outperform → Neutral $103 → $88
Mar-18-25 05:11AM
Mar-12-25 11:30AM
06:30AM
Mar-11-25 06:30AM
Mar-10-25 05:03AM
08:06AM Loading…
Mar-04-25 08:06AM
04:01AM
Mar-03-25 06:30AM
Feb-26-25 06:30AM
02:03AM
12:06AM
Feb-25-25 07:10AM
06:21AM
06:17AM
06:00AM
08:04AM Loading…
Feb-24-25 08:04AM
Feb-20-25 09:15AM
Feb-14-25 04:08AM
Feb-12-25 06:30AM
Feb-10-25 06:30AM
Feb-05-25 09:00AM
Jan-29-25 10:31AM
09:04AM
08:04AM
07:00AM
05:45AM
Jan-23-25 06:30AM
Jan-22-25 04:37PM
Jan-16-25 06:42AM
Jan-15-25 06:30AM
09:25AM Loading…
Jan-14-25 09:25AM
Jan-09-25 06:30AM
Jan-07-25 12:03PM
Dec-26-24 09:00PM
Dec-17-24 06:30AM
Dec-13-24 09:40AM
Dec-12-24 02:32PM
Dec-05-24 11:30AM
Nov-26-24 09:40AM
Nov-23-24 05:00AM
Nov-21-24 06:30AM
03:59AM
Nov-20-24 06:30AM
Nov-18-24 04:51PM
01:35PM
Nov-16-24 10:12AM
Nov-06-24 02:15AM
01:46AM
Nov-05-24 12:11PM
09:30AM
07:11AM
07:10AM
06:10AM
06:00AM
Oct-31-24 01:23PM
09:15AM
Oct-29-24 10:01AM
Oct-24-24 06:30AM
Oct-18-24 12:10PM
Oct-17-24 08:00AM
Oct-08-24 05:33PM
Oct-02-24 04:32PM
Oct-01-24 11:00AM
06:30AM
Sep-30-24 06:30AM
Sep-26-24 03:00PM
06:30AM
Sep-25-24 07:30AM
06:27AM
Sep-17-24 06:30AM
Sep-12-24 06:30AM
Sep-05-24 11:31AM
07:58AM
Aug-29-24 06:30AM
Aug-23-24 11:35AM
Aug-19-24 09:00AM
08:25AM
Aug-15-24 06:30AM
Aug-12-24 06:30AM
Aug-07-24 06:32AM
03:04AM
Aug-06-24 05:32PM
09:43AM
09:30AM
08:57AM
07:10AM
06:11AM
06:00AM
Aug-05-24 09:16AM
09:05AM
Jul-31-24 06:30AM
Jul-30-24 10:01AM
Jul-26-24 09:50AM
Jul-23-24 09:59AM
Jul-22-24 09:40AM
Jul-18-24 03:33AM
Jul-17-24 05:41PM
Jul-15-24 03:57AM
Jul-12-24 09:33AM
Jul-10-24 04:00PM
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LASKAWY PHILIP ADirectorMar 19 '25Sale71.042,604184,99924,805Mar 20 04:28 PM
Connett Bradford CCEO, NA Distribution GroupMar 19 '25Sale71.154,036287,16162,688Mar 20 04:19 PM
Connett Bradford COfficerMar 19 '25Proposed Sale71.154,036287,161Mar 19 04:46 PM
LASKAWY PHILIP ADirectorMar 19 '25Proposed Sale71.042,604184,999Mar 19 02:14 PM
KUEHN KURT PDirectorMar 05 '25Sale71.552,787199,39615,687Mar 06 04:31 PM
KUEHN KURT PDirectorMar 05 '25Proposed Sale71.552,787199,396Mar 05 04:45 PM
Ettinger Michael SEVP & Chief Operating OfficerNov 18 '24Sale75.0012,240918,00087,706Nov 20 04:15 PM
Ettinger Michael SOfficerNov 18 '24Proposed Sale75.0012,240918,000Nov 18 03:05 PM
McGlynn LoreleiSVP, Chief Human Res. OfficerSep 06 '24Sale69.3021,0351,457,72671,833Sep 09 05:19 PM
McGlynn LoreleiOfficerSep 06 '24Proposed Sale69.9321,0351,470,998Sep 06 11:38 AM
MLOTEK MARK EEVP, Chief Strategic OfficerAug 14 '24Sale69.123,000207,36087,851Aug 15 04:36 PM
MLOTEK MARK EOfficerAug 14 '24Proposed Sale69.123,000207,353Aug 14 12:27 PM
Siegel WalterSr. VP & Chief Legal OfficerJun 06 '24Sale69.474,134287,18939,526Jun 07 04:15 PM